Current through Register Vol. 56, No. 24, December 18, 2024
Section 13:39-14.1 - Protocol for pharmacists furnishing self-administered hormonal contraceptives(a) A pharmacist shall be authorized to furnish self-administered hormonal contraceptives to a patient, in accordance with standardized procedures and protocols jointly developed and approved by the Board and the State Board of Medical Examiners as set forth at N.J.A.C. 13:39 Appendix A (Protocol), a standing order issued by a licensed physician pursuant to the Protocol, and the rules in this chapter. If the licensed physician issuing the standing order is the New Jersey Commissioner of the Department of Health, or a designee, the standing order may have Statewide effect.(b) A pharmacist must keep a written copy of the Protocol and the standing order under which the pharmacist furnishes hormonal contraceptives at each pharmacy practice site at which the pharmacist furnishes self-administered hormonal contraceptives. The final page of the Protocol must include the names of each pharmacist authorized pursuant to this subchapter to furnish self-administered hormonal contraceptives at the pharmacy practice site. The pharmacist must make a copy of the Protocol and the standing order available upon the request of a representative of the Board.(c) Nothing in this subchapter or the Protocol shall be construed to expand the authority of a pharmacist to prescribe any prescription medication.(d) The requirements of this subchapter and the Protocol do not apply to a pharmacist dispensing a self-administered hormonal contraceptive pursuant to an individual prescription issued by a healthcare practitioner authorized to prescribe self-administeredhormonal contraceptives in the course of professional practice or to a nonprescription hormonal contraceptive; provided, however, that nothing in this subchapter shall prohibit any person from obtaining a nonprescription hormonal contraceptive pursuant to the Protocol. N.J. Admin. Code § 13:39-14.1
Adopted by 56 N.J.R. 906(a) effective 5/20/2024